相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Hypersensitivity Reactions to Platinum Agents and Taxanes
Lulu R. Tsao et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2022)
Do Steroids Matter? A Retrospective Review of Premedication for Taxane Chemotherapy and Hypersensitivity Reactions
Olivia M. Lansinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Incidence of infusion hypersensitivity reaction after withholding dexamethasone premedication in early breast cancer patients not experiencing two previous cycles of infusion hypersensitivity reaction for weekly paclitaxel chemotherapy
Napa Parinyanitikul et al.
SUPPORTIVE CARE IN CANCER (2018)
Meta-analysis of the effects of oral and intravenous dexamethasone premedication in the prevention of paclitaxel-induced allergic reactions
Fu-Chao Chen et al.
ONCOTARGET (2017)
Management of Hypersensitivity Reactions to Taxanes
Matthieu Picard
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2017)
Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines
S. Rosello et al.
ANNALS OF ONCOLOGY (2017)
Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions
Matthieu Picard et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction
Michael J. Berger et al.
SUPPORTIVE CARE IN CANCER (2015)
The diagnosis and management of anaphylaxis practice parameter: 2010 Update
Phillip Lieberman et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Oral premedication for the prevention of hypersensitivity reactions to paclitaxel
Jamal Zidan et al.
MEDICAL ONCOLOGY (2008)
Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL(R)-free formulation of paclitaxel
Thomas E. Stinchcombe
NANOMEDICINE (2007)
Management and preparedness for infusion and hypersensitivity reactions
Heinz-Josef Lenz
ONCOLOGIST (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy
T Sendo et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Premedication strategy for weekly paclitaxel
J Quock et al.
CANCER INVESTIGATION (2002)